↓ Skip to main content

Cochrane Database of Systematic Reviews

Interferon Beta for Primary Progressive Multiple Sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2010
Altmetric Badge

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
108 Mendeley
Title
Interferon Beta for Primary Progressive Multiple Sclerosis
Published in
Cochrane database of systematic reviews, January 2010
DOI 10.1002/14651858.cd006643.pub3
Pubmed ID
Authors

Juan Ignacio Rojas, Marina Romano, Agustín Ciapponi, Liliana Patrucco, Edgardo Cristiano

Abstract

This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006643. DOI: 10.1002/14651858.CD006643.pub2).Therapeutic trials with ss-interferon in Multiple Sclerosis (MS) have mainly focused on remitting-relapsing multiple sclerosis (RRMS), demonstrating a reduction in relapse rate. However, there is not enough evidence about their efficacy in patients with primary progressive multiple sclerosis (PPMS).

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Italy 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Spain 1 <1%
Unknown 103 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 18%
Researcher 18 17%
Student > Ph. D. Student 13 12%
Student > Bachelor 12 11%
Student > Doctoral Student 8 7%
Other 24 22%
Unknown 14 13%
Readers by discipline Count As %
Medicine and Dentistry 45 42%
Nursing and Health Professions 10 9%
Agricultural and Biological Sciences 9 8%
Neuroscience 6 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 14 13%
Unknown 20 19%